FH in Europe: Need for a registry
Drs Eric Bruckert and Kees Hovingh discuss the need for a European database on patients with Homozygous Familial Hypercholesterolemia (HoFH) and Heterozygous Familial Hypercholesterolemia HeFH to better understand the cardiovascular disease in this patent population and measure efficacy and safety of new medications
Prof. E. Bruckert - Hôpital Pitié-Salpêtrière, Paris, France
Dr. G.K. Hovingh - Internist, Academisch Medisch Centrum, Amsterdam
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.